Search fresh public links, source activity, and ready-to-use post angles for Pact Act Diabetes.
Fresh curated links around PACT Act diabetes are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
https://abcd.care/ Twitter: @ABCDDiab Primary research areas Metabolic and endocrine Grant types Clinical trial, Project(typically <4 years) Research stage Clinical resea...
abbott diabetics Anonymous (not verified) Mon, 08/24/2026 - 06:39 field_thread_url https://cafepharma.com/boards/threads/abbott-diabetics.291330/...
abbott diabetics Anonymous (not verified) Fri, 08/07/2026 - 00:29 field_thread_url https://cafepharma.com/boards/threads/abbott-diabetics.291330/...
MONDAY, Aug. 10, 2026 — The weight loss drug Zepbound might cut the risk of heart attack or stroke among type 2 diabetics with excess weight and heart problems, a new study says. P...
The Childhood Diabetes Reduction Act of 2025 would require health warning labels for certain foods and beverages, prohibit marketing of specified products to children, and expand f...
By Lara Viejo Over 29 million Americans suffer from diabetes, a disease consisting of the body’s inability to produce the necessary insulin to enable the ingested glucose to be use...
www.diabetes.org.uk Twitter: @DiabetesUK and @DUK_Research Primary research areas Metabolic and endocrine Additional research areas Cardiovascular, Eye, Inflammatory and immu...
A new study published in Nature Communications is putting a widely used class of diabetes medicines under the microscope, asking whether glucagon-like peptide-1 receptor agonists i...
Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring the PBM to stop preferring higher cost ver...
www.breakthrought1d.org Twitter: @BT1DUK Primary research areas Inflammatory and immune system, Metabolic and endocrine Additional research areas Cardiovascular, Eye, Mental h...
Type 2 diabetes has traditionally been a disease that has affected mostly middle-aged and older adults. But new research from the U.S. to be presented at the Annual Meeting of the...
State legislators including Senator John Liu rallied with doctors, patients, healthcare professionals, and community members on August 18 to urge Governor Hochul to sign their legi...
The pharmaceuticals and specialty products distributor plans to buy AdaptHealth's diabetes health business unit and medical supply provider Strive Medical in separate deals worth $...
Amylyx Pharmaceuticals’ avexitide led to statistically significant and clinically meaningful reductions in hypoglycemic events in patients with post-bariatric hypoglycemia (PBH). T...
A late-stage trial found the drug, which Amylyx bought for cheap in a bankruptcy auction, was effective at regulating blood sugar in patients who’d just undergone bariatric surgery...
DiabMart, a new UAE-based digital diabetes management platform, aims to help people living with diabetes manage their condition during the long periods between medical appointments...
Amylyx Pharmaceuticals’ $35 million bet on the GLP-1 receptor antagonist avexitide appears to have paid off, with the molecule cutting the number of dangerous blood sugar crashes b...
Background: Personalized follow-up for type 2 diabetes may improve the alignment between monitoring intensity and patient needs, but operational approaches that jointly consider fo...
Bacteria engineered to sense and reduce glucose levels could be the future of type 2 diabetes treatments, following pre-clinical trials on animal models.Continue ReadingCategory:
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.